Eur Rev Med Pharmacol Sci 2022; 26 (6): 1789-1789
DOI: 10.26355/eurrev_202203_28320

Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?

M. Tang, Q.-P. Xie, K. Zhu, X.-L. Fu

Department of Cardiology, Zhuzhou City Central Hospital, Zhuzhou, China. xieqiuping2000@163.com

Free PDF Download

To cite this article

M. Tang, Q.-P. Xie, K. Zhu, X.-L. Fu
Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 6
Pages: 1789-1789
DOI: 10.26355/eurrev_202203_28320

Keywords Related articles:

  1. Relapsing polychondritis associated with heart block
  2. Relapsing polychondritis following silicone breast implant: first description
  3. Vitamin D insufficiency is very frequent and linked to inflammatory biomarkers in relapsing polychondritis
  4. The theory of a “staphylococcus superantigen” in chronic rhinosinusitis with nasal polyps: myth or reality?
  5. Impact of QRS morphology on heart rate turbulence and heart rate variability after cardiac resynchronization therapy in patients with heart failure